Literature DB >> 17470334

Predicting survival in heart failure.

Viorel G Florea1, Inder S Anand.   

Abstract

Despite advances in the therapy of cardiovascular disorders, heart failure remains a challenging disease with a dismal prognosis. A plethora of variables have been shown to be related to survival in patients with heart failure. These include heart failure etiology, clinical presentation, ventricular performance, exercise capacity, neurohormones and, more recently, inflammatory and necrosis markers. In this review we briefly list established predictive markers and discuss whether survival can accurately be predicted in this condition.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17470334     DOI： 10.1007/bf02938352

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN： 1523-3782            Impact factor:   2.931


  84 in total

1.  Course and prognosis in patients > or = 70 years of age with congestive heart failure and normal versus abnormal left ventricular ejection fraction.

Authors:  R Pernenkil; J M Vinson; A S Shah; V Beckham; C Wittenberg; M W Rich
Journal:  Am J Cardiol       Date:  1997-01-15       Impact factor: 2.778

2.  Prognostic stratification of women with chronic heart failure referred for heart transplantation: relevance of gender as compared with gender-related characteristics.

Authors:  Francesco Grigioni; Andrea Barbieri; Antonio Russo; Letizia Reggianini; Silvia Bonatti; Luciano Potena; Francesca Fabbri; Fabio Coccolo; Gaia Magnani; Francesca Bursi; Carlo Magelli; Maria G Modena; Angelo Branzi
Journal:  J Heart Lung Transplant       Date:  2006-05-02       Impact factor: 10.247

3.  Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure. Second Prospective Randomised Study of Ibopamine on Mortality and Efficacy (PRIME II) Investigators.

Authors:  J R Hampton; D J van Veldhuisen; F X Kleber; A J Cowley; A Ardia; P Block; A Cortina; L Cserhalmi; F Follath; G Jensen; J Kayanakis; K I Lie; G Mancia; A M Skene
Journal:  Lancet       Date:  1997-04-05       Impact factor: 79.321

4.  Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.

Authors:  K Swedberg; P Eneroth; J Kjekshus; L Wilhelmsen
Journal:  Circulation       Date:  1990-11       Impact factor: 29.690

5.  Functional capacity of patients with chronic left ventricular failure. Relationship of bicycle exercise performance to clinical and hemodynamic characterization.

Authors:  J A Franciosa; S Ziesche; M Wilen
Journal:  Am J Med       Date:  1979-09       Impact factor: 4.965

6.  A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure.

Authors:  U Elkayam; J Amin; A Mehra; J Vasquez; L Weber; S H Rahimtoola
Journal:  Circulation       Date:  1990-12       Impact factor: 29.690

7.  Validation of a risk score for dying within 1 year of an admission for heart failure.

Authors:  Thomas S Rector; Sumit N Ringwala; Sudip N Ringwala; Inder S Anand
Journal:  J Card Fail       Date:  2006-05       Impact factor: 5.712

8.  A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST).

Authors:  R M Califf; K F Adams; W J McKenna; M Gheorghiade; B F Uretsky; S E McNulty; H Darius; K Schulman; F Zannad; E Handberg-Thurmond; F E Harrell; W Wheeler; J Soler-Soler; K Swedberg
Journal:  Am Heart J       Date:  1997-07       Impact factor: 4.749

9.  Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.

Authors:  H D White; R M Norris; M A Brown; P W Brandt; R M Whitlock; C J Wild
Journal:  Circulation       Date:  1987-07       Impact factor: 29.690

10.  Renal function as a predictor of outcome in a broad spectrum of patients with heart failure.

Authors:  Hans L Hillege; Dorothea Nitsch; Marc A Pfeffer; Karl Swedberg; John J V McMurray; Salim Yusuf; Christopher B Granger; Eric L Michelson; Jan Ostergren; Jan Hein Cornel; Dick de Zeeuw; Stuart Pocock; Dirk J van Veldhuisen
Journal:  Circulation       Date:  2006-02-07       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.